Skip to main content

Table 1 Characteristics of NSCLC patients

From: Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer

Items NSCLC patients (N = 265)
Age (years)
 Mean ± SD 62.0 ± 10.6
 Median (IQR) 62.0 (55.0–68.0)
Sex, No. (%)
 Male 205 (77.4)
 Female 60 (22.6)
History of smoke, No. (%) 150 (56.6)
History of drink, No. (%) 103 (38.9)
Hypertension, No. (%) 95 (35.8)
Hyperlipidemia, No. (%) 87 (32.8)
Diabetes, No. (%) 44 (16.6)
Pathological grade, No. (%)
 G1 44 (16.6)
 G2 160 (60.4)
 G3 61 (23.0)
Tumor size (cm)
 Mean ± SD 5.3 ± 2.1
 Median (IQR) 5.0 (4.0–7.0)
LYN metastasis, No. (%) 93 (35.1)
TNM stage, No. (%)
 I 86 (32.5)
 II 90 (34.0)
 III 89 (33.5)
CEA (ng/mL)
 Mean ± SD 47.7 ± 172.8
 Median (IQR) 6.2 (2.9–27.6)
  1. NSCLC non-small cell lung carcinoma, SD standard deviation, LYN lymph node, CEA carcinoembryonic antigen, IQR interquartile range